- Friday, October 26th at 6:30 P.M.
MICHAEL SUMMERS, PHD - HHMI investigator, Professor of Chemistry and Biochemistry, UMBC
"Mechanisms for Educating and Retaining a Diverse STEM Workforce"
Dr. Michael Summers is a HHMI investigator and Professor of Chemistry and Biochemistry at the University of Maryland, Baltimore County. Dr. Summers is an elected fellow of the AAAS, a member of the Advisory Council for the NIH Office of AIDS Research. He received the Carl Brändén Award of the Protein Society (2011), the American Association for the Advancement of Science (AAAS) Mentor Award (2003), the Emily M. Gray Award for Biophysical Society (2003), and the White House Presidential Award for Science Mentoring (2000). His research efforts are aimed at understanding how retroviruses assemble and how they specifically recognized and package their genetic material.
- Saturday, October 27th at 11:00 A.M.
ANDREW XIAO, PHD - Assistant Professor, Genetics, Yale University
"Epigenetic Regulations in Stem Cells and Development"
Dr. Andrew Xiao is a 2003 graduate alumna from the Department of Biochemistry and Biophysics at UNC Chapel Hill. He trained in the David Allis lab at Rockefeller as a postdoctoral fellow before joining as an Assistant Professor of Genetics at Yale University. His current research focuses on elucidating molecular mechanisms for mammalian stem cell biology, cellular reprogramming (iPS) and embryonic development, with an emphasis on histone variants, histone posttranslational modifications and chromatin remodeling complexes.
- Sunday, October 28th at 11:15 A.M.
JUDITH BOND, PHD - 2012 President, FASEB
"Beyond the PhD and Postdoc Experience"
Dr. Judith Bond has been Professor and Chair of Biochemistry and Molecular Biology at Penn State College of Medicine in Hershey, PA for the last 20 years. She is an Associate Editor of the Journal of Biological Chemistry and a Past President of the American Society for Biochemistry and Molecular Biology (ASBMB) from 2004-2006. Dr. Bond’s research on proteolysis, and particularly on unique and complex metalloproteases called meprins, has been funded continuously by the National Institutes of Health (NIH) for 34 years. She is the current President-elect of the Federation of American Societies for Experimental Biology (FASEB).